GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CodeLab Capital AS (OSL:CODE) » Definitions » Research & Development

CodeLab Capital AS (OSL:CODE) Research & Development : kr0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is CodeLab Capital AS Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. CodeLab Capital AS's Research & Development for the three months ended in Dec. 2024 was kr0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was kr0.00 Mil.

CodeLab Capital AS Research & Development Historical Data

The historical data trend for CodeLab Capital AS's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CodeLab Capital AS Research & Development Chart

CodeLab Capital AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial -57.72 -82.33 -39.31 -16.21 -

CodeLab Capital AS Quarterly Data
Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Mar24 Jun24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CodeLab Capital AS Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CodeLab Capital AS  (OSL:CODE) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

CodeLab Capital AS Research & Development Related Terms

Thank you for viewing the detailed overview of CodeLab Capital AS's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

CodeLab Capital AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CodeLab Capital AS (OSL:CODE) » Definitions » Research & Development
Comparable Companies
OSL:INDCT VEEV GEHC ASX:PME DOCS TEM TSE:2413 HQY WAY HKSE:02587 BTSG NSE:IKS SZSE:300253 PRVA HKSE:02228 CERT NSE:SAGILITY HKSE:01833 SDGR PINC
Traded in Other Exchanges
N/A
Address
Postboks 339 Skoyen, Oslo, NOR, 0213
Website
https://www.codelabcapital.com
CodeLab Capital AS is a holding company engaged in tech companies with its subsidiary. It makes software development tools for the B2B market. It is involved in R&D activities, developing software, and intellectual property. It provides cloud solutions for health professionals.

CodeLab Capital AS Headlines

No Headlines